Newly published data shows that multiple-reuse catheters pose a potential safety concern for people practicing intermittent catheterisation.
Given the great variability in the definitions used to diagnose Urinary Tract Infection (UTI), this review will aid in providing an overview of the joint clinical evidence between the different bladder management methods with regard to UTI risk.
According to the World Health Organization (WHO), women’s health is a concern of high priority as women face greater difficulties in getting the healthcare they need... and we couldn't agree more.
December's highlight article describes the results from an observational clinical study that followed 22 patients with multiple sclerosis (MS) for a period of 16 weeks. The aim of the study was to investigate whether the food supplement D-mannose would be feasible and safe for use as a prophylactic treatment for recurrent urinary tract infection (UTI).
November's highlight article describes the outcome of a health-economic evaluation, comparing hydrophilic-coated with non-coated catheters for intermittent catheterization. The study uses computer modeling to simulate a population with life-long intermittent catheter use.
The results show that from the age of 40, the life-long use of hydrophilic-coated instead of non-coated catheters avoids on average 18 complications per patient and reduces healthcare costs by $10,184 per patient. This translates into a quality of life gain of 0.55 quality-adjusted life-years (QALYs).